EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD

Sophie Monnerat iD, Julie Refardt iD, Laura Potasso iD, Christian Meier iD, Mirjam Christ-Crain iD

The Journal of Clinical Endocrinology & Metabolism · 18.09.2023 · 108 (10) · e1027-e1033

DOI: 10.1210/clinem/dgad238 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 25.04.2023. Verfasst von Sophie Monnerat und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, 4031 Basel, Switzerland. Hauptthemen laut MEDLINE: Hyponatremia. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swiss National Science Foundation, Swiss Endocrine Society.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Hyponatremia is associated with increased risk for osteoporosis. Preclinical studies in untreated hyponatremia suggest osteoclast upregulation, whereas a clinical study showed improved osteoblast function after hyponatremia normalization in hospitalized patients with syndrome of inappropriate antidiuresis (SIAD).

Objective

This work aimed to investigate the effect of an increase in sodium on bone turnover, that is, the ratio of the osteoblast marker procollagen type 1 N-terminal propeptide (P1NP) to the osteoclast marker cross-linked C-terminal telopeptide of type 1 collagen (CTX), in outpatients with chronic SIAD.

Methods

A predefined secondary analysis was conducted of the 2-month double-blind, crossover, placebo-controlled SANDx Trial (NCT03202667) performed from December 2017 to August 2021. Participants included 11 outpatients with chronic SIAD: 6 women, median age 73 years, who received a 4-week treatment with 25-mg empagliflozin or placebo. Main outcome measures included the relationship between the change in bone formation index (BFI), defined as P1NP/CTX, and the change in plasma sodium levels.

Results

Changes in sodium were positively correlated with changes in BFI and P1NP (BFI: ρ=.55; P < .001; P1NP: ρ=.45; P = .004) but not with CTX (P = .184) and osteocalcin (P = .149). A sodium increase of 1 mmol/l was associated with an increase of 5.21 in BFI (95% CI, 1.41-9.00; P = .013) and with an increase of 1.48 µg/l in P1NP (95% CI, .26-2.62; P = .03). The effect of sodium change on bone markers was independent of the study medication empagliflozin.

Conclusion

An increase in plasma sodium levels in outpatients with chronic hyponatremia due to SIAD, even when mild, was associated with an increase in bone formation index (P1NP/CTX) triggered by an increase in P1NP, a surrogate marker of osteoblast function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HyponatremiaHumansFemaleAgedBenzhydryl CompoundsCollagen Type IBiomarkersBone RemodelingSodiumOsteoblastsProcollagenPeptide FragmentsGlucosides

Stichwörter der Autor:innen

CTXP1NPempagliflozinhyponatremiaosteocalcinsyndrome of inappropriate antidiuresis

Substanzen

Benzhydryl CompoundsCollagen Type IBiomarkersSodiumProcollagenPeptide FragmentsempagliflozinGlucosides

Autor:innen und Institutionen

  • Department of Endocrinology, Diabetology and Metabolism, University Hospital Basel, 4031 Basel, Switzerland.
  • Department of Clinical Research, University of Basel, 4056 Basel, Switzerland.

ORCID-Profile: Sophie Monnerat, Julie Refardt, Laura Potasso, Christian Meier, Mirjam Christ-Crain

Förderung

  • Swiss National Science Foundation
  • Swiss Endocrine Society

Zitieren

APA

Monnerat, S., Refardt, J., Potasso, L., Meier, C., & Christ-Crain, M. (2023). An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD. The Journal of Clinical Endocrinology & Metabolism, 108(10), e1027-e1033. https://doi.org/10.1210/clinem/dgad238

Vancouver

Monnerat S, Refardt J, Potasso L, Meier C, Christ-Crain M. An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD. The Journal of Clinical Endocrinology & Metabolism. 2023;108(10):e1027-e1033. doi:10.1210/clinem/dgad238

BibTeX
@article{Monnerat2023,
  author = {Monnerat, Sophie and Refardt, Julie and Potasso, Laura and Meier, Christian and Christ-Crain, Mirjam},
  title = {An Increase in Plasma Sodium Levels Is Associated With an Increase in Osteoblast Function in Chronic SIAD},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2023},
  volume = {108},
  number = {10},
  pages = {e1027--e1033},
  doi = {10.1210/clinem/dgad238}
}
Kostenlos starten →